| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LILLY ELI & CO | 26,810 | 1,931,000 | 19.98% | ||
| 2 | EDWARDS LIFESCIENCES CORP | 17,443 | 1,539,000 | 15.92% | ||
| 3 | DEXCOM | 19,046 | 1,293,000 | 13.38% | ||
| 4 | ARATANA THERAPEUTICS INC COM | 218,515 | 1,206,000 | 12.48% | ||
| 5 | ALEXION PHARMACEUTIC | 8,599 | 1,197,000 | 12.38% | ||
| 6 | REGENERON PHARMACEUTICALS | 2,291 | 826,000 | 8.55% | ||
| 7 | ATHENA HEALTH INC. | 4,900 | 680,000 | 7.04% | ||
| 8 | ACADIA PHARMACEUTICALS INC COM | 21,552 | 603,000 | 6.24% | ||
| 9 | ALIGN TECHNOLOGY INC | 5,366 | 390,000 | 4.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-16-003245, filed 2016.05.12).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
